Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the... see more

TSX:EDT - Post Discussion

Spectral Medical Inc > Interview With Vantive Latin American North Manager
View:
Post by gebremeskel on Oct 25, 2024 11:57am

Interview With Vantive Latin American North Manager

Interview With Carlos Escobar - Vantive General Manager for Mexico, Central America, Puerto Rico and the Caribbean

24 October 2024

"Our strategy is to shift from focusing solely on one organ—kidney care—to supporting multiple organs. While kidney care remains our core business, we are expanding into the acute care space, which addresses organ failure in ICU patients. This segment, known as the acute business, is growing rapidly, with increasing demand for solutions that support not just kidney function, but also the liver, lungs, and patients with sepsis. These treatments are delivered through specialized devices used in ICU settings, rather than in home care environments."
Comment by Rickkie on Oct 25, 2024 1:07pm
Link to full interview. https://pharmaboardroom.com/interviews/carlos-escobar-general-manager-mexico-central-america-puerto-rico-and-caribbean-baxter-kidney-care-vantive/
Comment by hmmmmmmmm on Oct 25, 2024 2:39pm
Another amazing find!   Vantive first stated their "foundation" moving forward are patients in the ICU "who need critical interventions to help remove toxins"  To now they have added Sepsis to the desription of Vantive's focus. Can anyone list Vantive products that can do this other than PMX?  One might be able to argue the Oxiris filter- but it has ...more  
Comment by BlueJays9293 on Oct 25, 2024 8:36pm
It's almost like these Vantive executives are giddy at the companies new approach and can't hide their business strategy excitement.  They are almost talking like they already own Spectral.  Which is weird, cuz' last time I checked, they didn't.
Comment by mercedesman on Oct 26, 2024 9:05am
It would seem that Pablo's cousin Carlos has gone legit and inadvertently let it slip that he has found a new way to eventually rake in billions !  MM 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities